Please assess the completion status of the following clinical trial:

Trial Title: Comparison of FDG PET and Bone Scintigraphy/Labelled Leukocyte/Gallium Scintigraphy in Diabetic Foot Osteomyelitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diabetic patient with suspected diabetic foot osteomyelitis referred for nuclear medicine examination (bone scan and Gallium or labelled leukocytes).~* Being treated or followed by a physician at CHUM~Exclusion Criteria:~* Pregnant woman~* Breastfeeding patient~* Claustrophobia/patient unable to complete imaging procedure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Main arm (Type: EXPERIMENTAL): PET-CT imaging of the ankles and feet following injection of 18F-FDG

Based on this trial design, predict the completion outcome and termination type (if applicable).